DESCRIPTION: The broad, long-term objective is to reduce morbidity and
mortality caused by tumors occurring in the HNPCC syndrome. The first
task is to define the natural history of HNPCC (e.g. age-dependent risk,
spectrum of affected organs, clinical behavior) and the effect of
predictive testing on clinical screening and preventive measures. This
can be done by determining who is a carrier and who is not among as many
as 288 affected and 1169 unaffected at-risk members of 81 previously
diagnosed HNPCC families. The frequency of HNPCC will be determined by
studying one-fourth of all colorectal carcinomas and adenomas removed
in Finland. These will be screened for the replication error (RER)
phenomenon that is indicative of, but not specific for, HNPCC.
Individuals with RER-positive tumors will be screened for HNPCC
mutations. This study will comprise some 2500 individuals annually. As
there are almost no established procedures for the handling of data
regarding individual susceptibility to a common, adult-onset cancer, the
ethical and social aspects of this experiment in predictive testing will
be researched by means of repeated individual counseling and evaluation,
as well as by attempting to inform the medical profession, to educate the
public, and to provide expertise to lawmakers.
Error Notice
The database may currently be offline for maintenance and should be operational soon. If not, we have been notified of this error and will be reviewing it shortly.
We apologize for the inconvenience.
- The DCCPS Team.